CAS 1252637-35-6

Formula: C25H23F6N5O4S

InChI: InChI=1S/C25H23F6N5O4S/c1-35-11-15(10-33-35)14-2-3-19(17(8-14)24(26,27)28)41(39,40)16-9-18(20(37)34-22(13-32)4-5-22)36(12-16)21(38)23(6-7-23)25(29,30)31/h2-3,8,10-11,16,18H,4-7,9,12H2,1H3,(H,34,37)/t16-,18+/m1/s1

InChI key: KXAAIORSMACJSI-AEFFLSMTSA-N

SMILES: CN1C=C(C=N1)C2=CC(=C(C=C2)S(=O)(=O)[C@@H]3C[C@H](N(C3)C(=O)C4(CC4)C(F)(F)F)C(=O)NC5(CC5)C#N)C(F)(F)F

Petesicatib

CAS: 1252637-35-6

Petesicatib

Formula: C₂₅H₂₃F₆N₅O₄S

Purity: 99.5%

Molecular weight: 603.54

Ref: 54-BUP05528

(2S,4R)-N-(1-Cyanocyclopropyl)-4-[[4-(1-methyl-1H-pyrazol-4-yl)-2-(trifluoromethyl)phenyl]sulfonyl]-1-[[1-(trifluoromethyl)cyclopropyl]carbonyl]-2-pyrrolidinecarboxamide

CAS: 1252637-35-6

Formula: C₂₅H₂₃F₆N₅O₄S

Purity: 98%

Color and Shape: Solid

Molecular weight: 603.5366

Ref: IN-DA01N142

Petesicatib

CAS: 1252637-35-6

Petesicatib is a neuroprotective agent which has been shown to have nootropic and neuroprotective properties. It has been shown to inhibit the activity of receptor-2, tyrosine kinase, and protein kinase C in vitro. These effects are due to its ability to inhibit the conversion of retinoic acid into its active form by preventing the binding of retinoids to nuclear receptors. Petesicatib also binds to DNA and prevents the expression of proteins that are necessary for cells to divide. This drug is not selective for any one type of cell, but it does protect against toxic effects on neurons and astrocytes in vitro.

Formula: C₂₅H₂₃F₆N₅O₄S

Purity: Min. 95%

Molecular weight: 603.5 g/mol

Ref: 3D-CAC63735

Petesicatib

CAS: 1252637-35-6

Petesicatib is an inhibitor of cathepsin S. Petesicatib used in the research of immune diseases.

Formula: C₂₅H₂₃F₆N₅O₄S

Purity: 99.76% - 99.86%

Color and Shape: Solid

Molecular weight: 603.537

Ref: TM-T16474